Format

Send to

Choose Destination
Adv Exp Med Biol. 2014;818:181-96. doi: 10.1007/978-1-4471-6458-6_9.

SIRT6: a promising target for cancer prevention and therapy.

Author information

1
Department of Biology, University of Rochester, 432 Hutchison Hall, River Campus, Rochester, NY, 14627-0211, USA.

Abstract

Many of the pathologies associated with the aging process also contribute to tumor initiation, growth or metastasis. Insights from biogerontology may be instrumental for developing new therapies for cancer. This chapter highlights the rationale for combining biogerontology and cancer research to generate new strategies for cancer treatment. In particular, this chapter focuses on one gene, SIRT6, which has emerged as an important regulator of longevity in mammals and appears to have multiple biochemical functions, which antagonize tumor development and may be useful in cancer prevention and treatment.

PMID:
25001537
DOI:
10.1007/978-1-4471-6458-6_9
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center